Cohen Cyrille

Medicine & Life Sciences

1. T-Lymphocytes 100%
2. Neoplasms 53%
3. T-Cell Antigen Receptor 51%
4. Peptides 50%
5. Melanoma 36%
6. T-Cell Antigen Receptor Specificity 34%
7. Immunotherapy 33%
8. Chimeric Antigen Receptors 33%
9. Lymphocytes 29%
10. T-Cell Receptor Genes 24%
11. Neoplasm Antigens 23%
12. Antibodies 21%
13. Tumor-Infiltrating Lymphocytes 20%
14. Epitopes 20%
15. Major Histocompatibility Complex 20%
16. Antigens 20%
17. HLA-A2 Antigen 17%
18. T-Lymphocyte Epitopes 16%
19. Antigen Presentation 16%
20. Immunotoxins 15%
21. Adoptive Transfer 15%
22. MHC binding peptide 14%
23. Melanoma-Specific Antigens 14%
24. B-Cell Maturation Antigen 13%
25. Microsatellite Repeats 12%
26. Genes 11%
27. Clone Cells 10%
28. Beauty 10%
29. Histocompatibility Antigens Class I 10%
30. Antigen-Presenting Cells 10%
31. Genetic Therapy 9%
32. In Vitro Techniques 9%
33. Nucleotides 9%
34. Multiple Myeloma 8%
35. Therapeutics 8%
36. Heat-Shock Proteins 8%
37. Escherichia coli 8%
38. Gold 8%
39. Heterografts 8%
40. Cytokines 8%
41. Nanoparticles 7%
42. Human Activities 7%
43. leucyl-leucyl-phenylalanyl-glycyl-tyrosyl-prolyl-valyl-tyrosyl-valine 7%
44. Dendritic Cells 7%
45. Computer Simulation 7%
46. Ligands 7%
47. MART-1 Antigen 7%
48. Blood Cells 7%
49. Triple Negative Breast Neoplasms 7%
50. Terminally Ill 7%